IE912889A1 - Diphenylurea derivatives - Google Patents

Diphenylurea derivatives

Info

Publication number
IE912889A1
IE912889A1 IE288991A IE288991A IE912889A1 IE 912889 A1 IE912889 A1 IE 912889A1 IE 288991 A IE288991 A IE 288991A IE 288991 A IE288991 A IE 288991A IE 912889 A1 IE912889 A1 IE 912889A1
Authority
IE
Ireland
Prior art keywords
urea
carbon atoms
group containing
compound
formula
Prior art date
Application number
IE288991A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd
Publication of IE912889A1 publication Critical patent/IE912889A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/42—Y being a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IE288991A 1990-08-15 1991-08-14 Diphenylurea derivatives IE912889A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017892A GB9017892D0 (en) 1990-08-15 1990-08-15 New compositions of matter

Publications (1)

Publication Number Publication Date
IE912889A1 true IE912889A1 (en) 1992-02-26

Family

ID=10680688

Family Applications (1)

Application Number Title Priority Date Filing Date
IE288991A IE912889A1 (en) 1990-08-15 1991-08-14 Diphenylurea derivatives

Country Status (10)

Country Link
EP (1) EP0543891A1 (fr)
JP (1) JPH06500095A (fr)
AU (1) AU8411591A (fr)
CA (1) CA2089165A1 (fr)
GB (1) GB9017892D0 (fr)
IE (1) IE912889A1 (fr)
IL (1) IL99174A0 (fr)
PT (1) PT98684A (fr)
WO (1) WO1992003413A1 (fr)
ZA (1) ZA916412B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110151A (en) * 1993-06-30 1998-10-30 Sankyo Co Amid and urea histories and pharmaceutical preparations containing them
DE19624155A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Substituierte Benzoesäurederivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
CA2359244C (fr) 1999-01-13 2013-10-08 Bayer Corporation Diphenyle urees a substitution .omega.-carboxy aryle en tant qu'inhibiteurs de la kinase p38
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US6290478B1 (en) * 1999-07-16 2001-09-18 Scroll Technologies Eccentric back chamber seals for scroll compressor
WO2003068229A1 (fr) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation N-oxydes de pyridine, de quinoline, et d'isoquinoline en tant qu'inhibiteurs de kinase
DK1478358T3 (da) 2002-02-11 2013-10-07 Bayer Healthcare Llc Sorafenibtosylat til behandling af sygdomme kendetegnet ved unormal angiogenese
PT1626714E (pt) 2003-05-20 2007-08-24 Bayer Pharmaceuticals Corp Diarilureias para doenças mediadas por pdgfr
ES2297490T3 (es) 2003-07-23 2008-05-01 Bayer Pharmaceuticals Corporation Omega-carboxiarildifenilurea fluoro sustituida para el tratamiento y prevencion de enfermadades y afecciones.

Also Published As

Publication number Publication date
CA2089165A1 (fr) 1992-02-16
GB9017892D0 (en) 1990-09-26
WO1992003413A1 (fr) 1992-03-05
IL99174A0 (en) 1992-07-15
PT98684A (pt) 1992-07-31
ZA916412B (en) 1992-04-29
JPH06500095A (ja) 1994-01-06
AU8411591A (en) 1992-03-17
EP0543891A1 (fr) 1993-06-02

Similar Documents

Publication Publication Date Title
US4146631A (en) Benzamide derivatives
EP0404039B1 (fr) Médicaments contenant des dérivés di-tert.butylhydroxyphényliques et dérivés
US4161541A (en) Benzhydryl guanidines
EP0131221B1 (fr) Thioéthers, procédé pour leur préparation ainsi que der médicaments contenant ces composés
IE912889A1 (en) Diphenylurea derivatives
JPS6348873B2 (fr)
US5362744A (en) Tetrazole-substituted urea acat inhibitors
US5159114A (en) Acat inhibitory benzanilides
PL128998B1 (en) Process for preparing novel 2-amino-3-benzoylphenylacetamides and their derivatives
US4499105A (en) Carboxyimidamide derivatives
JPS642593B2 (fr)
US4912135A (en) Amide compounds
US5258406A (en) Sulfonimidamides
CA1276639C (fr) Derives d'aminobenzamide
EP0084292B1 (fr) Phénylalcénamides et alcénamides, procédés pour leur préparation et leur utilisation comme agents pharmaceutiques
US5658952A (en) 1-[4-(4'-sulfanilyl)phenyl]urea and derivatives for the treatment of Leishmaniasis
US5760087A (en) Glycylanilide derivatives, their preparation and their application in therapy
JPS6334866B2 (fr)
US4376731A (en) 1-Aziridine carboxylic acid derivatives with immunostimulant activity
WO1992003408A1 (fr) Derives de benzanilide
Weinstock et al. A structural modification study of procarbazine
JPH04173775A (ja) アニリド誘導体
CZ31297A3 (en) Pharmaceutical composition for inhibiting leukotrien biosynthesis and the use of urea derivative for preparing such pharmaceutical composition
EP0324472A2 (fr) Dérivés de cétènedithioacétals et procédés pour leur production et compositions les contenant
IE48767B1 (en) Novel oxothia compounds,processes for their preparation,pharmaceutical preparations containing these compounds and such compounds for therapeutic use